CoChat
Sign Up
Cited by 257Advanced Drug Delivery SystemsNanoparticle-Based Drug DeliveryDrug Solubulity and Delivery Systems

The DOI matches its Crossref record; 49 of the 52 references it cites were found in a registry or an index.

Effective oral delivery of insulin in animal models using vitamin B12-coated dextran nanoparticles

Chalasani, Kishore B., Russell-Jones, Gregory J., Jain, Akhlesh K., Diwan, Prakash V., Jain, Sanjay K.·2007·Journal of Controlled Release
DOI 10.1016/j.jconrel.2007.05.019
Open this paper in CoChat — free account

Abstract

The potential utility of vitamin B12 carrier system for the oral delivery of conjugated peptides/proteins and enhancement of nanoparticles (NPs) transport has been demonstrated. The present study aims to optimize the effectiveness of VB12-NPs conjugates using different levels of cross-linking, linked with different VB(12)-coatings and evaluates in animal models to investigate an efficient insulin carrier. Amino alkyl VB12 derivatives suitable for oral delivery were synthesized at 5'hydoxy ribose and e-propionamide sites via carbamate and ester/amide linkages, and were coupled to succinic acid modified dextran NPs of varied cross-linking. VB12 binding was confirmed by XPS analysis, and was quantified by HPLC (4.0 to 5.7% w/w of NPs). These polydisperse NPs conjugates showed higher size, high insulin entrapment and faster insulin release with low levels of cross-linking. These VB12-NPs conjugates (150-300 nm) showed profound (70-75% blood glucose reductions) and prolonged (54 h) anti-diabetic effects with biphasic behaviour in STZ diabetic rats. NPs with the low levels of cross-linking were found to be superior carriers, and were more effective with VB12 derivatives of carbamate linkage. The pharmacological availability relative to SC insulin was found to be 29.4%, which was superior compared to NPs conjugate of ester linked VB12 (1.5 fold) and relatively higher cross-linked particles (1.1 fold). Further, the NPs carrier demonstrated a similar oral insulin efficacy in congenital diabetic mice (60% reduction at 20 h). Significant quantities of plasma insulin were found in both animal models (231 and 197 muIU/ml). At two investigated doses, the carrier system shows dose response. Pre-dosing with a large excess of free VB12 minimized the observed activity, indicating predominance of VB12 mediated uptake. It is concluded that VB12-dextran NPs conjugate is a viable carrier for peroral insulin delivery to treat diabetics.

Overview

Integrity signals

Registry

Crossref · 10.1016/j.jconrel.2007.05.019

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Show all 52 references

3 of the 52 references couldn’t be matched to a known paper.

Research works printed but not linked: 1

  1. Uraizee, 2000, Development of a targeted mucoadhesive drug delivery system for the peroral administration of insulin, Drugs Made Ger., 43, 41

Cited by

Sorted by citations

Items 201–255 of 255

Related

See all

Metadata

Authors
Chalasani, K. B., Russell-Jones, G. J., Jain, A. K., Diwan, P. V., & Jain, S. K.
Affiliations
  • Indian Institute of Chemical Technology (IN)
  • Dr. Hari Singh Gour University (IN)
Corresponding author
  • Jain, Akhlesh K.
  • Jain, Sanjay K.
ORCID
Venue
Journal of Controlled Release
Publisher
Elsevier BV
Published
2007-09
Volume
122
Issue
2
Pages
141-150
ISSN
0168-3659 (ISSN-L)
DOI
10.1016/j.jconrel.2007.05.019
OpenAlex
W2093416811
Cited by
257
References
52
Citations by year
2026: 3 · 2025: 10 · 2024: 4 · 2023: 16 · 2022: 20 · 2021: 20 · 2020: 26 · 2019: 10 · 2018: 12 · 2017: 15 · 2016: 17 · 2015: 11 · 2014: 22 · 2013: 19 · 2012: 20
FWCI
4.89
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • Journal of Controlled Release (publishedVersion)
  • PubMed (publishedVersion)
Funders
Council of Scientific and Industrial Research, India
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
  • Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Drug Solubulity and Delivery Systems
Keywords
oral insulin delivery, vitamin B12, dextran nanoparticles, insulin, carbamate linkage, ester linkage, insulin secretion, blood glucose reduction, streptozotocin-induced diabetes, congenital diabetes
MeSH terms
Administration, Oral, Animals, Blood Glucose, Chemistry, Pharmaceutical, Cross-Linking Reagents, Dextrans, Diabetes Mellitus, Experimental, Diabetes Mellitus, Type 1, Dose-Response Relationship, Drug, Drug Carriers, Drug Compounding, Epichlorohydrin, Female, Hypoglycemic Agents, Insulin, Particle Size, Solubility, Species Specificity, Vitamin B 12, Mice, Inbred NOD, Rats, Wistar, Mice, Rats, Nanoparticles

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review